HF
AUTL

HRT Financial’s Autolus Therapeutics AUTL Stock Holding History

HRT Financial’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-210,172
Closed -$342K – 3165
2025
Q3 		$342K Buy
+210,172
New +$411K ﹤0.01% 2096
2021
Q3 		– Sell
-34,303
Closed -$227K – 3264
2021
Q2 		$227K Buy
34,303
+23,417
+215% +$145K ﹤0.01% 2313
2021
Q1 		$62K Buy
+10,886
New +$80.6K ﹤0.01% 2521

Other funds holding AUTL

MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

HRT Financial's AUTL Position: Q4 2025 in Review

HRT Financial sold out of Autolus Therapeutics (AUTL) in Q4 2025, closing a stake of 210,172 shares — an estimated $342K sold.

HRT Financial first reported a position in AUTL in Q1 2021 and held it in 3 quarters. The position peaked at $342K in Q3 2025. 89 funds tracked by Wall St. Rank hold AUTL as of Q4 2025.

  • HRT Financial reported no remaining Autolus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 210,172 Autolus Therapeutics shares in Q4 2025, an estimated $342K.
  • HRT Financial first reported a position in Autolus Therapeutics in Q1 2021 and held it in 3 quarters.
  • HRT Financial's Autolus Therapeutics position peaked at $342K in Q3 2025.
  • 89 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.